Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06489080

Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction

This prospective and prospective cohort study aims to establish a long-term follow-up cohort of patients with acute myocardial infarction, and combine multi-omics studies, wearable devices, artificial intelligence technology, etc., to describe the clinical characteristics of patients with acute myocardial infarction and the changing trend of treatment strategies, and analyze the related influencing factors. Explore new biomarkers and indicators affecting recurrent cardiovascular events for accurate risk stratification and risk prediction; To evaluate the factors affecting lifestyle intervention, drug efficacy and safety, and their impact on outcome, and improve chronic disease management mode, in order to improve the quality of life and prognosis of patients.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Acute Myocardial Infarction Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Artery Disease Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Division of Cardiology, Peking University First Hospital

Beijing, Beijing Municipality, 100034, China

Location status: Recruiting

Location contact

Jia Jia

CONTACT

[email protected]

861083572283

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Acute myocardial infarction is diagnosed meets the universal definition of acute myocardial infarction

Exclusion criteria

  • Did not agree to participate in the study

Treatment and study plan

Primary outcomes

  1. Major Adverse Cardiovascular Events

    Time frame: 5 years

    Composite end points of Cardiovascular death, nonfatal myocardial infarction, nonfatal ischemic stroke

Secondary outcomes

  1. Secondary Adverse Cardiovascular Events

    Time frame: 5 years

    All-cause death, non-cardiac death, myocardial infarction, hospitalization for coronary revascularization, hospitalization for heart failure, hospitalization for acute coronary syndrome, ischemic stroke, hemorrhagic stroke

Study contacts

Contact information is provided by the study sponsor or research team.

Bin Zhang, MD

CONTACT

[email protected]

861083572645

Jia Jia, MPH

CONTACT

[email protected]

861083572283

Sponsors and collaborators

Lead sponsor

Peking University First Hospital

Other

Registry information

Official study title

Survival and cArdiovascular eVents in Patients With Acute Myocardial Infarction in Peking UNiversity First Hospital: A lonG-term Cohort Study

Acronym: SAVING

Important dates

Study start
2024
Primary completion
2024
Study completion
2028
First posted
Jul 5, 2024
Registry last updated
Jul 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.